You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康哲药业(00867.HK)与泰诺麦博成立合资及进行战略合作
阿思达克 04-19 08:37
康哲药业(00867.HK)公布,通过全资附属公司与泰诺麦博达成一系列协议以进行战略合作,并对泰诺麦博进行股权投资及与其成立合营公司,公司将持有泰诺麦博之6%股权。後者开发全人源抗金黄色葡萄球菌α毒素抗体新药。

集团将与泰诺麦博成立合营公司,其中集团以现金出资,泰诺麦博将以包含其产品泰诺麦博全人源Hlα抗体在内的由相关协议约定的特定产品相关技术的大中华地区权益作为无形资产出资,集团与泰诺麦博将分别拥有合营公司50%权益。合营公司将委托集团负责所有合作产品在大中华地区的临床开发及商业化工作,及将委托泰诺麦博负责所有合作产品的生产。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account